News
News

Forbion announces successful dual listing of portfolio company argenx (ARGX) on NASDAQ

in company news

We are pleased to announce that our portfolio company argenx (Euronext Brussels: ARGX) has successfully been listed on the NASDAQ stock exchange, raising well over $100 million from selling 5.9 million new shares at $17.00 per share and from subsequently exercising the underwriters’ overallotment option to purchase 879,750 additional American Depositary Shares ("ADSs").

Subscribe